[ Thu, Dec 08th 2022 ]: WOPRAI
[ Thu, Dec 08th 2022 ]: WOPRAI
[ Thu, Dec 08th 2022 ]: WOPRAI
[ Thu, Dec 08th 2022 ]: WOPRAI
[ Thu, Dec 08th 2022 ]: WOPRAI
[ Thu, Dec 08th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Wed, Dec 07th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
Conor McNamara Initiated (BIO) at Buy and Held Target at $565 on, Dec 7th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Conor McNamara of RBC Capital, Initiated "Bio-Rad Laboratories, Inc." (BIO) at Buy and Held Target at $565 on, Dec 7th, 2022.
Conor has made no other calls on BIO in the last 4 months.
There is 1 other peer that has a rating on BIO. Out of the 1 peers that are also analyzing BIO, 0 agree with Conor's Rating of Hold.
This is the rating of the analyst that currently disagrees with Conor
- Dan Leonard of "Credit Suisse" Maintained at Buy with Decreased Target to $640 on, Friday, October 28th, 2022